Xspray Pharma Investor Relations Material
Latest events
Investor Update
Xspray Pharma
Q2 2025
15 Aug, 2025
Q1 2025
7 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Xspray Pharma
Access all reports
Xspray Pharma AB is a pharmaceutical company, which engages in the development of protein kinase inhibitors for targeted cancer treatments. Its product candidates include HyNap-Nilo and HyNap-DS. The company was founded by Lars Holmkvist, Ola Winqvist and Magnus Persson on April 3, 2003 and is headquartered in Solna, Sweden.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
XSPRAY
Country
🇸🇪 Sweden